Neutrophil-mediated regulation of innate and adaptive immunity: The role of myeloperoxidase

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Odobasic, Dragana ^a   Kitching, A Richard ^a,b   Holdsworth, Stephen R ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE; PEROXIDASE;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; ENZYME DEFICIENCY; ENZYME RELEASE; ENZYME SYNTHESIS; EXTRACELLULAR KILLING; HUMAN; IMMUNOREGULATION; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTRACELLULAR KILLING; MICROBIAL IMMUNITY; NEUTROPHIL; NONHUMAN; PROTEIN FUNCTION; REVIEW; TISSUE INJURY; ANIMAL; BACTERIUM; DEFICIENCY; ENZYMOLOGY; EXTRACELLULAR TRAP; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; BACTERIA; EXTRACELLULAR TRAPS; HUMANS; IMMUNITY, INNATE; MICE; NEUTROPHILS; PEROXIDASE;

EID: 84958787507     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/2349817     Document Type: Review

References (128)

1. T. N. Mayadas, X. Cullere, and C. A. Lowell, "The multifaceted functions of neutrophils, " Annual Review of Pathology: Mechanisms of Disease, vol. 9, pp. 181-218, 2014.
2. A. Schreiber and R. Kettritz, "The neutrophil in antineutrophil cytoplasmic autoantibody-associated vasculitis, " Journal of Leukocyte Biology, vol. 94, no. 4, pp. 623-631, 2013.
3. C.-W. Yang, B. S. I. Strong, M. J. Miller, and E. R. Unanue, "Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants, " Journal of Immunology, vol. 185, no. 5, pp. 2927-2934, 2010.
4. K. Agner, "Verdoperoxidase. A ferment isolated from leukocytes, " Acta Chemica Scandinavica, vol. 2, supplement 8, pp. 1-62, 1941.
5. J. Schultz and K. Kaminker, "Myeloperoxidase of the leucocyte of normal human blood. I. Content and localization, " Archives of Biochemistry and Biophysics, vol. 96, no. 3, pp. 465-467, 1962.
6. P. G. Rausch and T. G. Moore, "Granule enzymes of polymorphonuclear neutrophils: a phylogenetic comparison, " Blood, vol. 46, no. 6, pp. 913-919, 1975.
7. A. Bos, R. Wever, and D. Roos, "Characterization and quantification of the peroxidase in human monocytes, " Biochimica et Biophysica Acta, vol. 525, no. 1, pp. 37-44, 1978.
8. B. S. van derVeen, M. P. deWinther, and P. Heeringa, "Myeloperoxidase: molecular mechanisms of action and their relevance to human health and disease, " Antioxidants & Redox Signaling, vol. 11, no. 11, pp. 2899-2937, 2009.
9. K. E. Brown, E. M. Brunt, and J. W. Heinecke, "Immunohistochemical detection of myeloperoxidase and its oxidation products in Kupffer cells of human liver, " American Journal of Pathology, vol. 159, no. 6, pp. 2081-2088, 2001.
10. M. R. Rodrigues, D. Rodriguez, M. Russo, and A. Campa, "Macrophage activation includes high intracellular myeloperoxidase activity, " Biochemical and Biophysical Research Communications, vol. 292, no. 4, pp. 869-873, 2002.
11. R. M. Nagra, B. Becher, W. W. Tourtellotte et al., "Immunohistochemical and genetic evidence ofmyeloperoxidase involvement in multiple sclerosis, " Journal of Neuroimmunology, vol. 78, no. 1-2, pp. 97-107, 1997.
12. E. Malle, G. Waeg, R. Schreiber, E. F. Gröne, W. Sattler, and H.-J. Gröne, "Immunohistochemical evidence for the myeloperoxidase/H2O2/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochloritemodified proteins, " European Journal of Biochemistry, vol. 267, no. 14, pp. 4495-4503, 2000.
13. M.-L. Brennan, A. Gaur, A. Pahuja, A. J. Lusis, and W. F. Reynolds, "Mice lacking myeloperoxidase are more susceptible to experimental autoimmune encephalomyelitis, " Journal of Neuroimmunology, vol. 112, no. 1-2, pp. 97-105, 2001.
14. K. M. OSullivan, C. Y. Lo, S. A. Summers et al., "Renal participation ofmyeloperoxidase in antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis, " Kidney International, vol. 88, no. 5, pp. 1030-1046, 2015.
15. V. L. Shepherd and J. R. Hoidal, "Clearance of neutrophilderived myeloperoxidase by the macrophage mannose receptor," American Journal of Respiratory Cell and Molecular Biology, vol. 2, no. 4, pp. 335-340, 1990.
16. S. Sugiyama, Y. Okada, G. K. Sukhova, R. Virmani, J. W. Heinecke, and P. Libby, "Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes, " The American Journal of Pathology, vol. 158, no. 3, pp. 879-891, 2001.
17. M. Hansson, I. Olsson, and W. M. Nauseef, "Biosynthesis, processing, and sorting of humanmyeloperoxidase, " Archives of Biochemistry and Biophysics, vol. 445, no. 2, pp. 214-224, 2006.
18. A. Tobler, C. W. Miller, K. R. Johnson, M. E. Selsted, G. Rovera, and H. P. Koeffler, "Regulation of gene expression of myeloperoxidase during myeloid differentiation, " Journal of Cellular Physiology, vol. 136, no. 2, pp. 215-225, 1988.
19. W. M. Nauseef, S. J. McCormick, and M. Goedken, "Coordinated participation of calreticulin and calnexin in the biosynthesis of myeloperoxidase, " The Journal of Biological Chemistry, vol. 273, no. 12, pp. 7107-7111, 1998.
20. M. Shafran and S. Lyslova, "Purification and properties of myeloperoxidase from mice leukocytes, " Voprosy MeditsinskoѤ Khimii, vol. 21, pp. 629-633, 1975.
21. D. Odobasic, A. R. Kitching, Y. Yang et al., "Neutrophil myeloperoxidase regulates T-cell-driven tissue inflammation in mice by inhibiting dendritic cell function, " Blood, vol. 121, no. 20, pp. 4195-4204, 2013.
22. Y. Dang, G. M. Lowe, S. W. Edwards, and D. W. Galvani, "The effects of GM-CSF on myeloperoxidase release in normal and myelodysplastic neutrophils, " Leukemia Research, vol. 17, no. 12, pp. 1037-1044, 1993.
23. J. U. Holle, M. Windmöller, C. Lange, W. L. Gross, K. Herlyn, and E. Csernok, "Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis, " Rheumatology, vol. 52, no. 7, pp. 1183-1189, 2013.
24. W. W. Chatham, A. Turkiewicz, and W. D. Blackburn Jr. , "Determinants of neutrophil HOCl generation: ligand-dependent responses and the role of surface adhesion, " Journal of Leukocyte Biology, vol. 56, no. 5, pp. 654-660, 1994.
25. B. J. Bentwood and P. M. Henson, "The sequential release of granule constituents from human neutrophils, " Journal of Immunology, vol. 124, no. 2, pp. 855-862, 1980.
26. K. Kessenbrock, M. Krumbholz, U. Schönermarck et al., "Netting neutrophils in autoimmune small-vessel vasculitis, " Nature Medicine, vol. 15, no. 6, pp. 623-625, 2009.
27. H. Fliss, "Oxidation of proteins in rat heart and lungs by polymorphonuclear leukocyte oxidants, " Molecular and Cellular Biochemistry, vol. 84, no. 2, pp. 177-188, 1988.
28. C. C. Winterbourn, "Biological reactivity and biomarkers of the neutrophil oxidant, hypochlorous acid, " Toxicology, vol. 181-182, pp. 223-227, 2002.
29. D. T. Harwood, A. J. Kettle, S. Brennan, and C. C. Winterbourn, "Simultaneous determination of reduced glutathione, glutathione disulphide and glutathione sulphonamide in cells and physiological fluids by isotope dilution liquid chromatographytandem mass spectrometry, " Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, vol. 877, no. 28, pp. 3393-3399, 2009.
30. D. T. Harwood, A. J. Kettle, and C. C. Winterbourn, "Production of glutathione sulfonamide and dehydroglutathione from GSH by myeloperoxidase-derived oxidants and detection using a novel LC-MS/MS method, " Biochemical Journal, vol. 399, no. 1, pp. 161-168, 2006.
31. D. B. Learn, V. A. Fried, and E. L. Thomas, "Taurine and hypotaurine content of human leukocytes, " Journal of Leukocyte Biology, vol. 48, no. 2, pp. 174-182, 1990.
32. S. J. Klebanoff, A. J. Kettle, H. Rosen, C. C. Winterbourn, and W. M. Nauseef, "Myeloperoxidase: a front-line defender against phagocytosed microorganisms, " Journal of Leukocyte Biology, vol. 93, no. 2, pp. 185-198, 2013.
33. Y. Aratani, H. Koyama, S.-I. Nyui, K. Suzuki, F. Kura, and N. Maeda, "Severe impairment in early host defense against Candida albicans in mice deficient in myeloperoxidase, " Infection and Immunity, vol. 67, no. 4, pp. 1828-1836, 1999.
34. Y. Aratani, F. Kura, H. Watanabe et al., "Differential host susceptibility to pulmonary infections with bacteria and fungi in mice deficient inmyeloperoxidase, " Journal of Infectious Diseases, vol. 182, no. 4, pp. 1276-1279, 2000.
35. V. Brovkovych, X.-P. Gao, E. Ong et al., "Augmented inducible nitric oxide synthase expression and increased NO production reduce sepsis-induced lung injury and mortality in myeloperoxidase-null mice, " American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 295, no. 1, pp. L96-L103, 2008.
36. S. Bruns, O. Kniemeyer, M. Hasenberg et al., "Production of extracellular traps against aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin roda, " PLoS Pathogens, vol. 6, no. 4, Article ID e1000873, 2010.
37. V. Brinkmann, U. Reichard, C. Goosmann et al., "Neutrophil extracellular traps kill bacteria, " Science, vol. 303, no. 5663, pp. 1532-1535, 2004.
38. K. D. Metzler, T. A. Fuchs, W. M. Nauseef et al., "Myeloperoxidase is required for neutrophil extracellular trap formation: implications for innate immunity, " Blood, vol. 117, no. 3, pp. 953-959, 2011.
39. H. Parker, A. M. Albrett, A. J. Kettle, and C. C. Winterbourn, "Myeloperoxidase associated with neutrophil extracellular traps is active and mediates bacterial killing in the presence of hydrogen peroxide, " Journal of Leukocyte Biology, vol. 91, no. 3, pp. 369-376, 2012.
40. V. Papayannopoulos, K. D. Metzler, A. Hakkim, and A. Zychlinsky, "Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps, " Journal of Cell Biology, vol. 191, no. 3, pp. 677-691, 2010.
41. R. S. Keshari, A. Jyoti, M. Dubey et al., "Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition, " PLoS ONE, vol. 7, no. 10, Article ID e48111, 2012.
42. K. D. Metzler, C. Goosmann, A. Lubojemska, A. Zychlinsky, and V. Papayannopoulos, "A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis, " Cell Reports, vol. 8, no. 3, pp. 883-896, 2014.
43. H. Parker, M. Dragunow, M. B. Hampton, A. J. Kettle, and C. C. Winterbourn, "Requirements for NADPH oxidase and myeloperoxidase in neutrophil extracellular trap formation differ depending on the stimulus, " Journal of Leukocyte Biology, vol. 92, no. 4, pp. 841-849, 2012.
44. K. Akong-Moore, O. A. Chow, M. von Köckritz-Blickwede, and V. Nizet, "Influences of chloride and hypochlorite on neutrophil extracellular trap formation, " PLoS ONE, vol. 7, no. 8, Article ID e42984, 2012.
45. K. Friedrichs, S. Baldus, and A. Klinke, "Fibrosis in atrial fibrillation-role of reactive species and MPO, " Frontiers in Physiology, vol. 3, article 214, 2012.
46. P. P. Bradley, R. D. Christensen, and G. Rothstein, "Cellular and extracellular myeloperoxidase in pyogenic inflammation, " Blood, vol. 60, no. 3, pp. 618-622, 1982.
47. A. J. Kettle, T. Chan, I. Osberg et al., "Myeloperoxidase and protein oxidation in the airways of young children with cystic fibrosis, " American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 12, pp. 1317-1323, 2004.
48. E. Malle, C. Woenckhaus, G. Waeg, H. Esterbauer, E. F. Gröne, and H.-J. Gröne, "Immunological evidence for hypochloritemodified proteins in human kidney, " The American Journal of Pathology, vol. 150, no. 2, pp. 603-615, 1997.
49. L. K. Stamp, I. Khalilova, J. M. Tarr et al., "Myeloperoxidase and oxidative stress in rheumatoid arthritis, " Rheumatology, vol. 51, no. 10, Article ID kes193, pp. 1796-1803, 2012.
50. R. J. Johnson, W. G. Couser, E. Y. Chi, S. Adler, and S. J. Klebanoff, "New mechanism for glomerular injury. Myeloperoxidase-hydrogen peroxide-halide system, " The Journal of Clinical Investigation, vol. 79, no. 5, pp. 1379-1387, 1987.
51. R. J. Johnson, S. J. Klebanoff, R. F. Ochi et al., "Participation of the myeloperoxidase-H2O2-halide system in immune complex nephritis, " Kidney International, vol. 32, no. 3, pp. 342-349, 1987.
52. D. L. Lefkowitz, M. P. Gelderman, S. R. Fuhrmann et al., "Neutrophilicmyeloperoxidase-macrophage interactions perpetuate chronic inflammation associated with experimental arthritis, " Clinical Immunology, vol. 91, no. 2, pp. 145-155, 1999.
53. A. Lehners, S. Lange, G. Niemann et al., "Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice, " American Journal of Physiology-Renal Physiology, vol. 307, no. 4, pp. F407-F417, 2014.
54. R. A. Matthijsen, D. Huugen, N. T. Hoebers et al., "Myeloperoxidase is critically involved in the induction of organ damage after renal ischemia reperfusion, " The American Journal of Pathology, vol. 171, no. 6, pp. 1743-1752, 2007.
55. T. S. McMillen, J. W. Heinecke, and R. C. LeBoeuf, "Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice, " Circulation, vol. 111, no. 21, pp. 2798-2804, 2005.
56. D. Odobasic, A. R. Kitching, T. J. Semple, and S. R. Holdsworth, "Endogenous myeloperoxidase promotes neutrophil-mediated renal injury, but attenuates T cell immunity inducing crescentic glomerulonephritis, " Journal of the AmericanSociety of Nephrology, vol. 18, no. 3, pp. 760-770, 2007.
57. D. Odobasic, Y. Yang, R. C. M. Muljadi et al., "Endogenousmyeloperoxidase is a mediator of joint inflammation and damage in experimental arthritis, " Arthritis and Rheumatology, vol. 66, no. 4, pp. 907-917, 2014.
58. V. Rudolph, R. P. Andrié, T. K. Rudolph et al., "Myeloperoxidase acts as a profibrotic mediator of atrial fibrillation, " Nature Medicine, vol. 16, no. 4, pp. 470-474, 2010.
59. E. Villanueva, S. Yalavarthi, C. C. Berthier et al., "Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus, " Journal of Immunology, vol. 187, no. 1, pp. 538-552, 2011.
60. A. Warnatsch, M. Ioannou, Q. Wang, and V. Papayannopoulos, "Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis, " Science, vol. 349, no. 6245, pp. 316-320, 2015.
61. B. Shao, C. Tang, A. Sinha et al., "Humans with atherosclerosis have impaired ABCA1 cholesterol efflux and enhanced highdensity lipoprotein oxidation by myeloperoxidase, " Circulation Research, vol. 114, no. 11, pp. 1733-1742, 2014.
62. C. K. Smith, A. Vivekanandan-Giri, C. Tang et al., "Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus, " Arthritis and Rheumatology, vol. 66, no. 9, pp. 2532-2544, 2014.
63. R. Khandpur, C. Carmona-Rivera, A. Vivekanandan-Giri et al., "NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis, " Science Translational Medicine, vol. 5, no. 178, Article ID 178ra40, 2013.
64. S. M. Flint, E. F. McKinney, and K. G. C. Smith, "Emerging concepts in the pathogenesis of antineutrophil cytoplasmic antibody-associated vasculitis, " Current Opinion in Rheumatology, vol. 27, no. 2, pp. 197-203, 2015.
65. M. A. Cunningham, X. R. Huang, J. P. Dowling, P. G. Tipping, and S. R. Holdsworth, "Prominence of cell-mediated immunity effectors in pauci-immune glomerulonephritis, " Journal of the American Society of Nephrology, vol. 10, no. 3, pp. 499-506, 1999.
66. A. M. Coughlan, S. J. Freeley, and M. G. Robson, "Animal models of anti-neutrophil cytoplasmic antibody-associated vasculitis, " Clinical and Experimental Immunology, vol. 169, no. 3, pp. 229-237, 2012.
67. P.-Y. Gan, S. R. Holdsworth, A. R. Kitching, and J. D. Ooi, "Myeloperoxidase (MPO)-specific CD4+ T cells contribute to MPO-anti-neutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis, " Cellular Immunology, vol. 282, no. 1, pp. 21-27, 2013.
68. R. Kettritz, "How anti-neutrophil cytoplasmic autoantibodies activate neutrophils, " Clinical and Experimental Immunology, vol. 169, no. 3, pp. 220-228, 2012.
69. A.-J. Ruth, A. R. Kitching, R. Y. Q. Kwan et al., "Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis, " Journal of the American Society of Nephrology, vol. 17, no. 7, pp. 1940-1949, 2006.
70. H. Xiao, P. Heeringa, P. Hu et al., "Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice, " Journal of Clinical Investigation, vol. 110, no. 7, pp. 955-963, 2002.
71. L. Harper, D. Radford, T. Plant, M. Drayson, D. Adu, and C. O. S. Savage, "IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients, " Arthritis & Rheumatism, vol. 44, no. 4, pp. 921-930, 2001.
72. J. D. Ooi, J. Chang, M. J. Hickey et al., "The immunodominant myeloperoxidase T-cell epitope induces local cell-mediated injury in antimyeloperoxidase glomerulonephritis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 39, pp. E2615-E2624, 2012.
73. S. Sangaletti, C. Tripodo, C. Chiodoni et al., "Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens tomyeloid dendritic cells toward ANCA induction and associated autoimmunity, " Blood, vol. 120, no. 15, pp. 3007-3018, 2012.
74. A. J. Roth, J. D. Ooi, J. J. Hess et al., "Epitope specificity determines pathogenicity and detectability in anca-associated vasculitis, " Journal of Clinical Investigation, vol. 123, no. 4, pp. 1773-1783, 2013.
75. M. P. Kuligowski, R. Y. Q. Kwan, C. Lo et al., "Antimyeloperoxidase antibodies rapidly induce α4-integrin-dependent glomerular neutrophil adhesion, " Blood, vol. 113, no. 25, pp. 6485-6494, 2009.
76. H. Xiao, P. Heeringa, P. Hu et al., "Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice, " Journal of Clinical Investigation, vol. 110, no. 7, pp. 955-963, 2002.
77. A. Goldwich, M. Burkard, M. Ölke et al., "Podocytes are nonhematopoietic professional antigen-presenting cells, " Journal of the American Society of Nephrology, vol. 24, no. 6, pp. 906-916, 2013.
78. C. Iking-Konert, S. Vogt, M. Radsak, C. Wagner, G. M. Hänsch, and K. Andrassy, "Polymorphonuclear neutrophils inWegeners granulomatosis acquire characteristics of antigen presenting cells, " Kidney International, vol. 60, no. 6, pp. 2247-2262, 2001.
79. P. A. Knolle, T. Germann, U. Treichel et al., "Endotoxin downregulates T cell activation by antigen-presenting liver sinusoidal endothelial cells, " Journal of Immunology, vol. 162, no. 3, pp. 1401-1407, 1999.
80. D. V. Ostanin, E. Kurmaeva, K. Furr et al., "Acquisition of antigen-presenting functions by neutrophils isolated frommice with chronic colitis, " Journal of Immunology, vol. 188, no. 3, pp. 1491-1502, 2012.
81. A.-K. Tide, T. Sjögren, M. Svensson et al., "2-Thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation, " The Journal of Biological Chemistry, vol. 286, no. 43, pp. 37578-37589, 2011.
82. W. Zheng, R. Warner, R. Ruggeri et al., "PF-1355, A mechanismbased myeloperoxidase inhibitor, prevents immune complex vasculitis and anti-glomerular basement membrane glomerulonephritis, " Journal of Pharmacology and Experimental Therapeutics, vol. 353, no. 2, pp. 288-298, 2015.
83. C. Liu, R. Desikan, Z. Ying et al., "Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model, " PLoS ONE, vol. 7, no. 12, Article IDe50767, 2012.
84. D. Lau, H. Mollnau, J. P. Eiserich et al., "Myeloperoxidase mediates neutrophil activation by association with CD11b/CD18 integrins, " Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 2, pp. 431-436, 2005.
85. D. El Kebir, L. József, W. Pan, and J. G. Filep, "Myeloperoxidase delays neutrophil apoptosis through CD11b/CD18 integrins and prolongs inflammation, " Circulation Research, vol. 103, no. 4, pp. 352-359, 2008.
86. M. W. Johansson, M. Patarroyo, F. Oberg, A. Siegbahn, and K. Nilsson, "Myeloperoxidase mediates cell adhesion via the alpha Mbeta 2 integrin (Mac-1, CD11b/CD18), " Journal of Cell Science, vol. 110, part 9, pp. 1133-1139, 1997.
87. K. Grattendick, R. Stuart, E. Roberts et al., "Alveolar macrophage activation by myeloperoxidase: a model for exacerbation of lung inflammation, " American Journal of Respiratory Cell and Molecular Biology, vol. 26, no. 6, pp. 716-722, 2002.
88. D. L. Lefkowitz, E. Roberts, K. Grattendick et al., "The endothelium and cytokine secretion: the role of peroxidases as immunoregulators, " Cellular Immunology, vol. 202, no. 1, pp. 23-30, 2000.
89. S. Bennouna, S. K. Bliss, T. J. Curiel, and E. Y. Denkers, "Crosstalk in the innate immune system: neutrophils instruct recruitment and activation of dendritic cells during microbial infection, " The Journal of Immunology, vol. 171, no. 11, pp. 6052-6058, 2003.
90. S. Bennouna and E. Y. Denkers, "Microbial antigen triggers rapid mobilization of TNF-alpha to the surface of mouse neutrophils transforming them into inducers of high-level dendritic cell TNF-alpha production, " The Journal of Immunology, vol. 174, no. 8, pp. 4845-4851, 2005.
91. F. C. Weber, T. Németh, J. Z. Csepregi et al., "Neutrophils are required for both the sensitization and elicitation phase of contact hypersensitivity, " Journal of Experimental Medicine, vol. 212, no. 1, pp. 15-22, 2015.
92. H. R. Hampton, J. Bailey, M. Tomura, R. Brink, and T. Chtanova, "Microbe-dependent lymphatic migration of neutrophils modulates lymphocyte proliferation in lymph nodes, " Nature Communications, vol. 6, article 7139, 2015.
93. C. Beauvillain, P. Cunin, A. Doni et al., "CCR7 is involved in the migration of neutrophils to lymph nodes, " Blood, vol. 117, no. 4, pp. 1196-1204, 2011.
94. C. V. Gorlino, R. P. Ranocchia, M. F. Harman et al., "Neutrophils exhibit differential requirements for homing molecules in their lymphatic and blood trafficking into draining lymph nodes, "The Journal of Immunology, vol. 193, no. 4, pp. 1966-1974, 2014.
95. J. Pillay, V. M. Kamp, E. Van Hoffen et al., "A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1, " Journal of Clinical Investigation, vol. 122, no. 1, pp. 327-336, 2012.
96. D. Odobasic, R. C. Muljadi, K. M. OSullivan et al., "Suppression of autoimmunity and renal disease in pristane-induced lupus by myeloperoxidase, " Arthritis & Rheumatology, vol. 67, no. 7, pp. 1868-1880, 2015.
97. V. Abadie, E. Badell, P. Douillard et al., "Neutrophils rapidly migrate via lymphatics after Mycobacterium bovis BCG intradermal vaccination and shuttle live bacilli to the draining lymph nodes, " Blood, vol. 106, no. 5, pp. 1843-1850, 2005.
98. J. Marcinkiewicz, B. Nowak, A. Grabowska, M. Bobek, L. Petrovska, and B. Chain, "Regulation of murine dendritic cell functions in vitro by taurine chloramine, amajor product of the neutrophil myeloperoxidase-halide system, " Immunology, vol. 98, no. 3, pp. 371-378, 1999.
99. C. L. Hawkins, "The role of hypothiocyanous acid (HOSCN) in biological systems, " Free Radical Research, vol. 43, no. 12, pp. 1147-1158, 2009.
100. H. Xiong, C. Zhu, F. Li et al., "Inhibition of interleukin-12 p40 transcription and NF-κB activation by nitric oxide in murine macrophages and dendritic cells, " Journal of Biological Chemistry, vol. 279, no. 11, pp. 10776-10783, 2004.
101. E. M. Behrens, U. Sriram, D. K. Shivers et al., "Complement receptor 3 ligation of dendritic cells suppresses their stimulatory capacity, "The Journal of Immunology, vol. 178, no. 10, pp. 6268-6279, 2007.
102. E. Blouin, L. Halbwachs-Mecarelli, and P. Rieu, "Redox regulation of β2-integrin CD11b/CD18 activation, " European Journal of Immunology, vol. 29, no. 11, pp. 3419-3431, 1999.
103. T. K. Nowling and G. S. Gilkeson, "Mechanisms of tissue injury in lupus nephritis, " Arthritis Research and Therapy, vol. 13, no. 6, article 250, 2011.
104. W. H. Reeves, P. Y. Lee, J. S. Weinstein, M. Satoh, and L. Lu, "Induction of autoimmunity by pristane and other naturally occurring hydrocarbons, " Trends in Immunology, vol. 30, no. 9, pp. 455-464, 2009.
105. H. Bouali, P. Nietert, T. M. Nowling et al., "Association of the G-463A myeloperoxidase gene polymorphism with renal disease in African Americans with systemic lupus erythematosus, " Journal of Rheumatology, vol. 34, no. 10, pp. 2028-2034, 2007.
106. D. Pohlers, K. Nissler, O. Frey et al., "Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen-induced arthritis: influence on T helper cell activation, " Clinical and Experimental Immunology, vol. 135, no. 3, pp. 409-415, 2004.
107. D. Kutter, P. Devaquet, G. Vanderstocken, J. M. Paulus, V. Marchal, and A. Gothot, "Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit ?" Acta Haematologica, vol. 104, no. 1, pp. 10-15, 2000.
108. M. P. Kuligowski, A. R. Kitching, and M. J. Hickey, "Leukocyte recruitment to the inflamed glomerulus: a critical role for platelet-derived P-selectin in the absence of rolling, " Journal of Immunology, vol. 176, no. 11, pp. 6991-6999, 2006.
109. X. R. Huang, S. R. Holdsworth, and P. G. Tipping, "Evidence for delayed-type hypersensitivity mechanisms in glomerular crescent formation, " Kidney International, vol. 46, no. 1, pp. 69-78, 1994.
110. P. G. Tipping, X. R. Huang, M. Qi, G. Y. Van, and W. W. Tang, "Crescentic glomerulonephritis in CD4-and CD8-deficient mice: requirement for CD4 but not CD8 cells, " The American Journal of Pathology, vol. 152, no. 6, pp. 1541-1548, 1998.
111. J. L. Eyles, M. J. Hickey, M. U. Norman et al., "A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis, " Blood, vol. 112, no. 13, pp. 5193-5201, 2008.
112. C. Mauri, C.-Q. Q. Chu, D. Woodrow, L. Mori, and M. Londei, "Treatment of a newly established transgenic model of chronic arthritis with nondepleting anti-CD4 monoclonal antibody, " The Journal of Immunology, vol. 159, no. 10, pp. 5032-5041, 1997.
113. L. Svensson, J. Jirholt, R. Holmdahl, and L. Jansson, "B celldeficient mice do not develop type II collagen-induced arthritis (CIA), " Clinical and Experimental Immunology, vol. 111, no. 3, pp. 521-526, 1998.
114. B. T. Wipke and P. M. Allen, "Essential role of neutrophils in the initiation and progression of amurine model of rheumatoid arthritis, " The Journal of Immunology, vol. 167, no. 3, pp. 1601-1608, 2001.
115. R. Cramer, M. R. Soranzo, and P. Dri, "Incidence of myeloperoxidase deficiency in an area of northern Italy: histochemical, biochemical and functional studies, " British Journal of Haematology, vol. 51, no. 1, pp. 81-87, 1982.
116. M. Kitahara, H. J. Eyre, Y. Simonian, C. L. Atkin, and S. J. Hasstedt, "Hereditary myeloperoxidase deficiency, " Blood, vol. 57, no. 5, pp. 888-893, 1981.
117. C. Larrocha, M. Fernandez de Castro, G. Fontan, A. Viloria, J. L. Fernández-Chacón, and C. Jiménez, "Hereditarymyeloperoxidase deficiency: study of 12 cases, " Scandinavian Journal of Haematology, vol. 29, no. 5, pp. 389-397, 1982.
118. M. F. Parry, R. K. Root, J. A. Metcalf, K. K. Delaney, L. S. Kaplow, and W. J. Richar, "Myeloperoxidase deficiency: prevalence and clinical significance, " Annals of Internal Medicine, vol. 95, no. 3, pp. 293-301, 1981.
119. R. I. Lehrer and M. J. Cline, "Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection, " Journal of Clinical Investigation, vol. 48, no. 8, pp. 1478-1488, 1969.
120. C. Nguyen and H. P. Katner, "Myeloperoxidase deficiency manifesting as pustular candidal dermatitis, " Clinical Infectious Diseases, vol. 24, no. 2, pp. 258-260, 1997.
121. D. Kutter, "Prevalence of myeloperoxidase deficiency: population studies using Bayer-Technicon automated hematology, " Journal of Molecular Medicine, vol. 76, no. 10, pp. 669-675, 1998.
122. T. O. Hirche, J. P. Gaut, J. W. Heinecke, and A. Belaaouaj, "Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense, " The Journal of Immunology, vol. 174, no. 3, pp. 1557-1565, 2005.
123. B. Korkmaz, T. Moreau, and F. Gauthier, "Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions, " Biochimie, vol. 90, no. 2, pp. 227-242, 2008.
124. B. Shao, A. Belaaouaj, C. L. M. J. Verlinde, X. Fu, and J. W. Heinecke, "Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of serine proteinases by myeloperoxidase, " Journal of Biological Chemistry, vol. 280, no. 32, pp. 29311-29321, 2005.
125. P. Dri, R. Cramer, R. Menegazzi, and P. Patriarca, "Increased degranulation of human myeloperoxidase-deficient polymorphonuclear leucocytes, " British Journal of Haematology, vol. 59, no. 1, pp. 115-125, 1985.
126. O. Stendahl, B. I. Coble, C. Dahlgren, J. Hed, and L. Molin, "Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient, " The Journal of Clinical Investigation, vol. 73, no. 2, pp. 366-373, 1984.
127. G. Ramsaransing, A. Teelken, V. M. Prokopenko, A. V. Arutjunyan, and J. De Keyser, "Low leucocyte myeloperoxidase activity in patients with multiple sclerosis, " Journal of Neurology Neurosurgery and Psychiatry, vol. 74, no. 7, pp. 953-955, 2003.
128. K. Uchimura, A. Nagasaka, R. Hayashi et al., "Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus, " Journal of Diabetes and its Complications, vol. 13, no. 5-6, pp. 264-270, 1999.